newest glp-1 medications for type 2 diabetes 2025 New Guidelines in GLP-1 Pipeline Update: November 2025
Description
Your insurer may require failure documentation on semaglutide or a new step-therapy form
Still in trials: Retatrutide is not yet FDA-approved
Some focus mainly on dispensing medication, while others begin with a medical evaluation and provide ongoing care
You can adjust your injection schedule to fit lifestyle changes, though maintaining a consistent day and time each week optimizes the medication's steady-state effect
